Skip to main content
Erschienen in: Neuroradiology 3/2012

01.03.2012 | Diagnostic Neuroradiology

Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers

verfasst von: Rishi Awasthi, Ram K. S. Rathore, Priyanka Soni, Prativa Sahoo, Ashish Awasthi, Nuzhat Husain, Sanjay Behari, Rohit K. Singh, Chandra M. Pandey, Rakesh K. Gupta

Erschienen in: Neuroradiology | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The purpose of the present study was to look for the possible predictors which might discriminate between high- and low-grade gliomas by pooling dynamic contrast-enhanced (DCE)-perfusion derived indices and immunohistochemical markers.

Methods

DCE-MRI was performed in 76 patients with different grades of gliomas. Perfusion indices, i.e., relative cerebral blood volume (rCBV), relative cerebral blood flow (rCBF), permeability (k trans and k ep), and leakage (v e) were quantified. MMP-9-, PRL-3-, HIF-1α-, and VEGF-expressing cells were quantified from the excised tumor tissues. Discriminant function analysis using these markers was used to identify discriminatory variables using a stepwise procedure. To look for correlations between immunohistochemical parameters and DCE metrics, Pearson's correlation coefficient was also used.

Results

A discriminant function for differentiating between high- and low-grade tumors was constructed using DCE-MRI-derived rCBV, k ep, and v e. The form of the functions estimated are “D 1 = 0.642 × rCBV + 0.591 × k ep − 1.501 × v e − 1.550” and “D 2 = 1.608 × rCBV + 3.033 × k ep + 5.508 × v e − 8.784” for low- and high-grade tumors, respectively. This function classified overall 92.1% of the cases correctly (89.1% high-grade tumors and 100% low-grade tumors). In addition, VEGF expression correlated with rCBV and rCBF, whereas MMP-9 expression correlated with k ep. A significant positive correlation of HIF-1α with rCBV and VEGF expression was also found.

Conclusion

DCE-MRI may be used to differentiate between high-grade and low-grade brain tumors non-invasively, which may be helpful in appropriate treatment planning and management of these patients. The correlation of its indices with immunohistochemical markers suggests that this imaging technique is useful in tissue characterization of gliomas.
Literatur
1.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCrossRef Louis DN, Ohgaki H, Wiestler OD et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109PubMedCrossRef
2.
Zurück zum Zitat Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1998) Grading of astrocytomas. A simple and reproducible method. Cancer 62(10):2152–2165CrossRef Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P (1998) Grading of astrocytomas. A simple and reproducible method. Cancer 62(10):2152–2165CrossRef
3.
Zurück zum Zitat Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma. J Neurosurg 79(4):533–536PubMedCrossRef Kondziolka D, Lunsford LD, Martinez AJ (1993) Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low grade) astrocytoma. J Neurosurg 79(4):533–536PubMedCrossRef
4.
Zurück zum Zitat Petrella JR, Provenzale JM (2000) MR perfusion imaging of the brain: techniques and applications. Am J Roentgenol 175(1):207–219 Petrella JR, Provenzale JM (2000) MR perfusion imaging of the brain: techniques and applications. Am J Roentgenol 175(1):207–219
5.
Zurück zum Zitat Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41–51PubMed Aronen HJ, Gazit IE, Louis DN et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191(1):41–51PubMed
6.
Zurück zum Zitat Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echoplanar perfusion MR imaging. Radiology 223(1):11–29PubMedCrossRef Cha S, Knopp EA, Johnson G et al (2002) Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echoplanar perfusion MR imaging. Radiology 223(1):11–29PubMedCrossRef
7.
Zurück zum Zitat Pauliah M, Saxena V, Haris M, Husain N, Rathore RK, Gupta RK (2007) Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging 25(9):1292–1299PubMedCrossRef Pauliah M, Saxena V, Haris M, Husain N, Rathore RK, Gupta RK (2007) Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma. Magn Reson Imaging 25(9):1292–1299PubMedCrossRef
8.
Zurück zum Zitat Singh A, Haris M, Rathore D, Purwar A et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871–880PubMedCrossRef Singh A, Haris M, Rathore D, Purwar A et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871–880PubMedCrossRef
9.
Zurück zum Zitat Haris M, Gupta RK, Singh A et al (2008) Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology 50(6):531–540PubMedCrossRef Haris M, Gupta RK, Singh A et al (2008) Differentiation of infective from neoplastic brain lesions by dynamic contrast-enhanced MRI. Neuroradiology 50(6):531–540PubMedCrossRef
10.
Zurück zum Zitat Haris M, Kumar S, Raj MK et al (2008) Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas. Radiat Med 26(3):140–150PubMedCrossRef Haris M, Kumar S, Raj MK et al (2008) Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas. Radiat Med 26(3):140–150PubMedCrossRef
11.
Zurück zum Zitat Awasthi R, Verma SK, Haris M, Singh A, Behari S, Jaiswal AK (2010) Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma. J Comput Assist Tomogr 34(1):82–88PubMedCrossRef Awasthi R, Verma SK, Haris M, Singh A, Behari S, Jaiswal AK (2010) Comparative evaluation of dynamic contrast-enhanced perfusion with diffusion tensor imaging metrics in assessment of corticospinal tract infiltration in malignant glioma. J Comput Assist Tomogr 34(1):82–88PubMedCrossRef
12.
Zurück zum Zitat Ferrara N, Devis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4–25PubMedCrossRef Ferrara N, Devis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18(1):4–25PubMedCrossRef
13.
Zurück zum Zitat Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9(3):211–220PubMedCrossRef Veikkola T, Alitalo K (1999) VEGFs, receptors and angiogenesis. Semin Cancer Biol 9(3):211–220PubMedCrossRef
14.
Zurück zum Zitat An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM (1998) Stabilization of wild-type p53 by hypoxia-inducible factor-1 alpha. Nature 392(6674):405–408PubMedCrossRef An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV, Neckers LM (1998) Stabilization of wild-type p53 by hypoxia-inducible factor-1 alpha. Nature 392(6674):405–408PubMedCrossRef
15.
Zurück zum Zitat Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273(20):11995–11998PubMedCrossRef Blagosklonny MV, An WG, Romanova LY, Trepel J, Fojo T, Neckers L (1998) p53 inhibits hypoxia-inducible factor-stimulated transcription. J Biol Chem 273(20):11995–11998PubMedCrossRef
16.
Zurück zum Zitat VanMeter TE, Rooprai HK, Kibble MM et al (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53(2):213–235PubMedCrossRef VanMeter TE, Rooprai HK, Kibble MM et al (2001) The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis. J Neurooncol 53(2):213–235PubMedCrossRef
17.
Zurück zum Zitat Levicar N, Nuttall RK, Lah TT (2003) Proteases in brain tumour progression. Acta Neurochir Wien 145(9):825–838PubMedCrossRef Levicar N, Nuttall RK, Lah TT (2003) Proteases in brain tumour progression. Acta Neurochir Wien 145(9):825–838PubMedCrossRef
18.
Zurück zum Zitat Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489–01PubMedCrossRef Rao JS (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3(7):489–01PubMedCrossRef
19.
Zurück zum Zitat Yong VW (2005) Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6(12):931–944PubMedCrossRef Yong VW (2005) Metalloproteinases: mediators of pathology and regeneration in the CNS. Nat Rev Neurosci 6(12):931–944PubMedCrossRef
20.
Zurück zum Zitat Forsyth PA, Wong H, Laing TD et al (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79(11–12):1828–1835PubMedCrossRef Forsyth PA, Wong H, Laing TD et al (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79(11–12):1828–1835PubMedCrossRef
21.
Zurück zum Zitat Jadhav U, Chigurupati S, Lakka SS, Mohanam S (2004) Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25(5):1407–1414PubMed Jadhav U, Chigurupati S, Lakka SS, Mohanam S (2004) Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endothelial cells. Int J Oncol 25(5):1407–1414PubMed
22.
Zurück zum Zitat Liang F, Luo Y, Dong Y et al (2008) Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase. J Biol Chem 283(16):10339–10346PubMedCrossRef Liang F, Luo Y, Dong Y et al (2008) Translational control of C-terminal Src kinase (Csk) expression by PRL3 phosphatase. J Biol Chem 283(16):10339–10346PubMedCrossRef
23.
Zurück zum Zitat Saha S, Bardelli A, Buckhaults P et al (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294(5545):1343–1346PubMedCrossRef Saha S, Bardelli A, Buckhaults P et al (2001) A phosphatase associated with metastasis of colorectal cancer. Science 294(5545):1343–1346PubMedCrossRef
24.
Zurück zum Zitat Wu X, Zeng H, Zhang X et al (2004) Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164(6):2039–2054PubMedCrossRef Wu X, Zeng H, Zhang X et al (2004) Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164(6):2039–2054PubMedCrossRef
25.
Zurück zum Zitat Parker BS, Argani P, Cook BP et al (2004) Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 64(21):7857–7866PubMedCrossRef Parker BS, Argani P, Cook BP et al (2004) Alterations in vascular gene expression in invasive breast carcinoma. Cancer Res 64(21):7857–7866PubMedCrossRef
26.
Zurück zum Zitat Kong L, Li Q, Wang L, Liu Z, Sun T (2007) The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology 27(6):516–521PubMedCrossRef Kong L, Li Q, Wang L, Liu Z, Sun T (2007) The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas. Neuropathology 27(6):516–521PubMedCrossRef
27.
Zurück zum Zitat Singh A, Haris M, Rathore D et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871–880PubMedCrossRef Singh A, Haris M, Rathore D et al (2007) Quantification of physiological and hemodynamic indices using T(1) dynamic contrast-enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 26(4):871–880PubMedCrossRef
28.
Zurück zum Zitat Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257PubMedCrossRef Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407(6801):249–257PubMedCrossRef
29.
Zurück zum Zitat Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967PubMedCrossRef Asahara T, Murohara T, Sullivan A et al (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964–967PubMedCrossRef
30.
Zurück zum Zitat Kassner A, Thornhill R (2011) Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging. Meth Mol Biol 686:229–245CrossRef Kassner A, Thornhill R (2011) Measuring the integrity of the human blood-brain barrier using magnetic resonance imaging. Meth Mol Biol 686:229–245CrossRef
31.
Zurück zum Zitat Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A (2009) Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? Magn Reson Imaging 27(9):1216–1222PubMedCrossRef Vidarsson L, Thornhill RE, Liu F, Mikulis DJ, Kassner A (2009) Quantitative permeability magnetic resonance imaging in acute ischemic stroke: how long do we need to scan? Magn Reson Imaging 27(9):1216–1222PubMedCrossRef
32.
Zurück zum Zitat Haris M, Husain N, Singh A et al (2008) Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. J Comput Assist Tomogr 32(6):955–965PubMedCrossRef Haris M, Husain N, Singh A et al (2008) Dynamic contrast-enhanced derived cerebral blood volume correlates better with leak correction than with no correction for vascular endothelial growth factor, microvascular density, and grading of astrocytoma. J Comput Assist Tomogr 32(6):955–965PubMedCrossRef
33.
Zurück zum Zitat Cher LM, Murone C, Lawrentschuk N et al (2006) Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 47(3):410–418PubMed Cher LM, Murone C, Lawrentschuk N et al (2006) Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. J Nucl Med 47(3):410–418PubMed
34.
Zurück zum Zitat Alvarez JI, Teale JM (2007) Evidence for differential changes of junctional complex proteins in murine neurocysticerosis dependent upon CNS vasculature. Brain Res 1169:98–111PubMedCrossRef Alvarez JI, Teale JM (2007) Evidence for differential changes of junctional complex proteins in murine neurocysticerosis dependent upon CNS vasculature. Brain Res 1169:98–111PubMedCrossRef
35.
Zurück zum Zitat Zhao Y, Xiao A, diPierro CG et al (2010) An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. Am J Pathol 176(6):3032–3049PubMedCrossRef Zhao Y, Xiao A, diPierro CG et al (2010) An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. Am J Pathol 176(6):3032–3049PubMedCrossRef
Metadaten
Titel
Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers
verfasst von
Rishi Awasthi
Ram K. S. Rathore
Priyanka Soni
Prativa Sahoo
Ashish Awasthi
Nuzhat Husain
Sanjay Behari
Rohit K. Singh
Chandra M. Pandey
Rakesh K. Gupta
Publikationsdatum
01.03.2012
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 3/2012
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-011-0874-y

Weitere Artikel der Ausgabe 3/2012

Neuroradiology 3/2012 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.